非常抱歉，
你要访问的页面不存在，
非常抱歉，
你要访问的页面不存在，
非常抱歉，
你要访问的页面不存在，
验证码：
职称:Intermittent Lecturer in Entrepreneurial Studies
所属学校:University of Michigan-Ann Arbor
所属院系:Entrepreneurial Studies
所属专业:Entrepreneurial and Small Business Operations, Other
联系方式:(734) 615-5002
Jack Ball is CEO and a board member at Solulink, a San Diego biotech tools companies supplying technology that enables faster and quantitative conjugation of biomolecules with higher efficiencies and yields. He is President, Tyball Associates, LLC, a consulting company bringing 21st century sales and marketing strategies that are highly capital efficient, to companies in the biotech tools space. Mr. Ball also serves part-time as a Mentor-in-Residence at the Office of Tech Transfer, University of Michigan where he assists faculty and staff in commercializing the products they have developed in their laboratories. He is an Adjunct Professor at the University of Michigan, Ross Business School in Entrepreneurial Studies. In addition he serves on the board of directors of the following five companies: 3D Biomatrix, IntelliCyt, RealBio Technology, Swift Bioscience and ViroCyt Mr. Ball has a long and proven record for bringing life science products to market and capitalizing on existing product potential. Most recently he was Chief Commercial Officer at Accuri Cytometers where he developed a novel commercialization model that was highly capital efficient. He and the management team sold the company to Becton Dickinson for $205M in March 2011. Prior to Accuri Cytometers, he was CEO of Amnis Corporation, a venture backed technology start-up developing and selling high-end imaging flow cytometers. He has also served as Chief Commercial Officer for Molecular Probes, Inc., the world leader in reagents for cell analysis, including flow cytometry consumables. Prior to that he was with Orchid Biosciences as Sr. VP and General Manager and with Amersham Pharmacia Biotech Inc., where he rose to President, Region North America and was responsible for sales, marketing, and customer support for all products sold in North America.
Jack Ball is CEO and a board member at Solulink, a San Diego biotech tools companies supplying technology that enables faster and quantitative conjugation of biomolecules with higher efficiencies and yields. He is President, Tyball Associates, LLC, a consulting company bringing 21st century sales and marketing strategies that are highly capital efficient, to companies in the biotech tools space. Mr. Ball also serves part-time as a Mentor-in-Residence at the Office of Tech Transfer, University of Michigan where he assists faculty and staff in commercializing the products they have developed in their laboratories. He is an Adjunct Professor at the University of Michigan, Ross Business School in Entrepreneurial Studies. In addition he serves on the board of directors of the following five companies: 3D Biomatrix, IntelliCyt, RealBio Technology, Swift Bioscience and ViroCyt Mr. Ball has a long and proven record for bringing life science products to market and capitalizing on existing product potential. Most recently he was Chief Commercial Officer at Accuri Cytometers where he developed a novel commercialization model that was highly capital efficient. He and the management team sold the company to Becton Dickinson for $205M in March 2011. Prior to Accuri Cytometers, he was CEO of Amnis Corporation, a venture backed technology start-up developing and selling high-end imaging flow cytometers. He has also served as Chief Commercial Officer for Molecular Probes, Inc., the world leader in reagents for cell analysis, including flow cytometry consumables. Prior to that he was with Orchid Biosciences as Sr. VP and General Manager and with Amersham Pharmacia Biotech Inc., where he rose to President, Region North America and was responsible for sales, marketing, and customer support for all products sold in North America.
